These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20048201)

  • 1. Too much, too little, or just right?: untangling endogenous erythropoietin in heart failure.
    Felker GM
    Circulation; 2010 Jan; 121(2):191-3. PubMed ID: 20048201
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythropoietin and outcome prediction in patients with heart failure: the plot thickens..
    George J
    Eur Heart J; 2008 Jun; 29(12):1481-2. PubMed ID: 18504246
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythropoietin, haemoglobin, heart failure, and mortality.
    Diskin CJ
    Eur Heart J; 2008 Nov; 29(21):2695; author reply 2695-6. PubMed ID: 18786914
    [No Abstract]   [Full Text] [Related]  

  • 4. Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients.
    van der Meer P; Lok DJ; Januzzi JL; de la Porte PW; Lipsic E; van Wijngaarden J; Voors AA; van Gilst WH; van Veldhuisen DJ
    Eur Heart J; 2008 Jun; 29(12):1510-5. PubMed ID: 18495690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure.
    van der Meer P; Voors AA; Lipsic E; Smilde TD; van Gilst WH; van Veldhuisen DJ
    J Am Coll Cardiol; 2004 Jul; 44(1):63-7. PubMed ID: 15234408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anemia and chronic heart failure implications and treatment options.
    Anand IS
    J Am Coll Cardiol; 2008 Aug; 52(7):501-11. PubMed ID: 18687241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal function, erythropoietin, and anemia of older persons: the InCHIANTI study.
    Ble A; Fink JC; Woodman RC; Klausner MA; Windham BG; Guralnik JM; Ferrucci L
    Arch Intern Med; 2005 Oct; 165(19):2222-7. PubMed ID: 16246987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin and anemia: biological markers that cannot be ignored in diabetic retinopathy.
    DeNiro M; Al-Mohanna FA
    Med Hypotheses; 2012 Apr; 78(4):555-6. PubMed ID: 22336090
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythropoietin in renal transplant recipients: studies based on recombinant human erythropoietin radioimmunoassay.
    Ward HJ; Sun CH; Paul WL; Koyle MA; Yanagawa N; Lee DB
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2041-2. PubMed ID: 2652668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum erythropoietin levels and bone marrow hematopoiesis in patients with aplastic anemia].
    Ogawa T
    Rinsho Ketsueki; 1996 Jul; 37(7):604-9. PubMed ID: 8779780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia in chronic heart failure: etiology and treatment options.
    Westenbrink BD; de Boer RA; Voors AA; van Gilst WH; van Veldhuisen DJ
    Curr Opin Cardiol; 2008 Mar; 23(2):141-7. PubMed ID: 18303527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers.
    George J; Patal S; Wexler D; Abashidze A; Shmilovich H; Barak T; Sheps D; Keren G
    Arch Intern Med; 2005 Jun; 165(11):1304-9. PubMed ID: 15956012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure.
    van der Putten K; Braam B; Jie KE; Gaillard CA
    Nat Clin Pract Nephrol; 2008 Jan; 4(1):47-57. PubMed ID: 18094727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of anemia, right-heart catheterization and neurohormones in chronic heart failure.
    Gardner RS; McDonagh TA
    Expert Rev Cardiovasc Ther; 2006 Jan; 4(1):51-7. PubMed ID: 16375628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congestive heart failure-related anemia and a role for erythropoietin.
    Akram K; Pearlman BL
    Int J Cardiol; 2007 May; 117(3):296-305. PubMed ID: 16901559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of erythropoietin in heart failure management.
    Caiola K; Cheng JW
    Ann Pharmacother; 2004 Dec; 38(12):2145-9. PubMed ID: 15494385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-erythropoietin effects on ventricular remodeling, left and right systolic function, pulmonary pressure, and hospitalizations in patients affected with heart failure and anemia.
    Palazzuoli A; Silverberg DS; Calabrò A; Spinelli T; Quatrini I; Campagna MS; Franci B; Nuti R
    J Cardiovasc Pharmacol; 2009 Jun; 53(6):462-7. PubMed ID: 19455052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proinflammatory state and circulating erythropoietin in persons with and without anemia.
    Ferrucci L; Guralnik JM; Woodman RC; Bandinelli S; Lauretani F; Corsi AM; Chaves PH; Ershler WB; Longo DL
    Am J Med; 2005 Nov; 118(11):1288. PubMed ID: 16271918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
    Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
    Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of erythropoietin in anemia after heart transplantation.
    Gleissner CA; Klingenberg R; Staritz P; Koch A; Ehlermann P; Wiggenhauser A; Dengler TJ
    Int J Cardiol; 2006 Oct; 112(3):341-7. PubMed ID: 16309765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.